Statistics for Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials
Total visits
views | |
---|---|
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials | 164 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 14 |
April 2025 | 32 |
May 2025 | 15 |
June 2025 | 6 |
File Visits
views | |
---|---|
Orkin2020Three-AAM.pdf | 1295 |
java.util.UUID:f30383b9-aae2-4786-b21c-18fb42e1c646 | 220 |
java.util.UUID:7dae456e-19ea-43d4-8e73-f7316e99dd4f | 31 |
java.util.UUID:bfd4a461-1b4a-47b0-9c28-61ea6f728996 | 6 |
Top country views
views | |
---|---|
United States | 80 |
Japan | 14 |
South Korea | 13 |
China | 12 |
Indonesia | 6 |
Chile | 3 |
Colombia | 3 |
France | 3 |
Brazil | 2 |
Canada | 2 |
Ethiopia | 2 |
Hong Kong SAR China | 2 |
India | 2 |
Sweden | 2 |
Switzerland | 1 |
Costa Rica | 1 |
Spain | 1 |
United Kingdom | 1 |
Italy | 1 |
Malaysia | 1 |
Russia | 1 |
Turkey | 1 |
Top city views
views | |
---|---|
Wilmington | 39 |
Fairfield | 10 |
Suita | 6 |
Ann Arbor | 5 |
Beijing | 5 |
Houston | 4 |
Meadville | 4 |
Baltimore | 3 |
Bogotá | 3 |
Cambridge | 3 |
Fairfax | 3 |
Kawasaki | 3 |
Santiago | 3 |
Seoul | 3 |
Adachi | 2 |
Hayward | 2 |
Paris | 2 |
Ponta Grossa | 2 |
Toronto | 2 |
Ahmedabad | 1 |
Arès | 1 |
Banjar Pacung | 1 |
Brissogne | 1 |
Istanbul | 1 |
Lakewood | 1 |
London | 1 |
Marshville | 1 |
New York | 1 |
Osaka | 1 |
Portland | 1 |
San José | 1 |
Seremban | 1 |
Shanghai | 1 |
Sueca | 1 |
Surabaya | 1 |
Tokyo | 1 |
Umeå | 1 |
Zurich | 1 |